Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells.

Lai YH, Cheng J, Cheng D, Feasel ME, Beste KD, Peng J, Nusrat A, Moreno CS.

BMC Cell Biol. 2011 Nov 19;12:50. doi: 10.1186/1471-2121-12-50.

2.

Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.

Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS.

Cancer Res. 2009 Jan 15;69(2):709-17. doi: 10.1158/0008-5472.CAN-08-3415.

3.

Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion.

Jafarnejad SM, Ardekani GS, Ghaffari M, Martinka M, Li G.

Oncogene. 2013 Apr 25;32(17):2131-9. doi: 10.1038/onc.2012.239.

4.

Inhibition of melanoma cell proliferation by targeting Wnt/β-catenin pathway through Sox4 RNA interference.

Cai H, Ni A, Li W, Li J.

J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):565-9. doi: 10.1007/s11596-011-0491-3.

PMID:
21823023
5.

Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.

Yang M, Wang J, Wang L, Shen C, Su B, Qi M, Hu J, Gao W, Tan W, Han B.

Prostate. 2015 Sep;75(13):1363-75. doi: 10.1002/pros.23017.

PMID:
26015225
6.

Derivation of an endogenous small RNA from double-stranded Sox4 sense and natural antisense transcripts in the mouse brain.

Ling KH, Brautigan PJ, Moore S, Fraser R, Cheah PS, Raison JM, Babic M, Lee YK, Daish T, Mattiske DM, Mann JR, Adelson DL, Thomas PQ, Hahn CN, Scott HS.

Genomics. 2016 Mar;107(2-3):88-99. doi: 10.1016/j.ygeno.2016.01.006.

7.

SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.

Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD.

Mol Cancer. 2015 Feb 3;14:24. doi: 10.1186/s12943-014-0284-y.

8.

ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.

Wang L, Li Y, Yang X, Yuan H, Li X, Qi M, Chang YW, Wang C, Fu W, Yang M, Zhang J, Han B.

Prostate. 2014 May;74(6):647-58. doi: 10.1002/pros.22783.

PMID:
24435928
9.

Nuclear AXIN2 represses MYC gene expression.

Rennoll SA, Konsavage WM Jr, Yochum GS.

Biochem Biophys Res Commun. 2014 Jan 3;443(1):217-22. doi: 10.1016/j.bbrc.2013.11.089.

10.

β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells.

Wang SH, Li N, Wei Y, Li QR, Yu ZP.

Mol Med Rep. 2014 Mar;9(3):973-8. doi: 10.3892/mmr.2014.1889.

PMID:
24401947
11.

SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.

Wang L, Zhang J, Yang X, Chang YW, Qi M, Zhou Z, Zhang J, Han B.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):301-7. doi: 10.1038/pcan.2013.25.

PMID:
23917306
12.

SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.

Sun R, Jiang B, Qi H, Zhang X, Yang J, Duan J, Li Y, Li G.

Cell Death Dis. 2015 Nov 19;6:e1990. doi: 10.1038/cddis.2015.290.

13.

Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.

Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM.

Mol Cell Biol. 2007 Nov;27(22):7802-15.

14.

Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.

Lyros O, Rafiee P, Nie L, Medda R, Jovanovic N, Otterson MF, Behmaram B, Gockel I, Mackinnon A, Shaker R.

Neoplasia. 2015 Jul;17(7):598-611. doi: 10.1016/j.neo.2015.07.006.

15.

Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.

Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M, Ottewell PD.

Breast Cancer Res. 2012 May 25;14(3):R86.

16.

mrhl RNA, a long noncoding RNA, negatively regulates Wnt signaling through its protein partner Ddx5/p68 in mouse spermatogonial cells.

Arun G, Akhade VS, Donakonda S, Rao MR.

Mol Cell Biol. 2012 Aug;32(15):3140-52. doi: 10.1128/MCB.00006-12.

17.

Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.

Aktary Z, Kulak S, Mackey J, Jahroudi N, Pasdar M.

J Cell Sci. 2013 Jul 15;126(Pt 14):3031-42. doi: 10.1242/jcs.120642.

18.

Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

Müller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Köhler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H.

Mol Cell Biol. 2004 Apr;24(7):2890-904.

19.

Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.

Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y.

Oncogene. 2004 Jan 29;23(4):964-72.

PMID:
14661054
20.

The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses T(H)2 differentiation.

Kuwahara M, Yamashita M, Shinoda K, Tofukuji S, Onodera A, Shinnakasu R, Motohashi S, Hosokawa H, Tumes D, Iwamura C, Lefebvre V, Nakayama T.

Nat Immunol. 2012 Jul 1;13(8):778-86. doi: 10.1038/ni.2362.

Items per page

Supplemental Content

Support Center